Marigold Bioextracts Profile
Key Indicators
- Authorised Capital ₹ 2.60 Cr
- Paid Up Capital ₹ 2.51 Cr
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 5.00 Cr
- Revenue Growth 274.84%
- Profit Growth 37.43%
- Ebitda 15.02%
- Net Worth 64.84%
- Total Assets 17.14%
About Marigold Bioextracts
Marigold Bioextracts Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 December 2012 and has a history of 12 years and two months. Its registered office is in Warangal, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 2.60 Cr and a paid-up capital of Rs 2.51 Cr.
The company currently has active open charges totaling ₹5.00 Cr.
Rammohan Chunchu and Anil Gandamalla serve as directors at the Company.
Company Details
- Location
Warangal, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2012PTC084921
- Company No.
084921
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2012
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Marigold Bioextracts?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Gandamalla  | Managing Director | 18-Jan-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rammohan Chunchu | Director | 19-Dec-2012 | Current |
Financial Performance of Marigold Bioextracts.
Marigold Bioextracts Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 274.84% increase. The company also saw a substantial improvement in profitability, with a 37.43% increase in profit. The company's net worth Soared by an impressive increase of 64.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marigold Bioextracts?
In 2016, Marigold Bioextracts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2017 | Others | ₹5.00 Cr | Open |
How Many Employees Work at Marigold Bioextracts?
Unlock and access historical data on people associated with Marigold Bioextracts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marigold Bioextracts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marigold Bioextracts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
